# Glioblastoma Multiforme (GBM) Proton vs. Intensity Modulated Radiotherapy (IMRT)

> **NCT01854554** · PHASE2 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 90 (actual)

## Conditions studied

- Brain Cancer

## Interventions

- **RADIATION:** IMPT
- **RADIATION:** IMRT
- **BEHAVIORAL:** Cognitive Tests
- **BEHAVIORAL:** Questionnaires

## Key facts

- **NCT ID:** NCT01854554
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-05-17
- **Primary completion:** 2021-10-13
- **Final completion:** 2021-10-13
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2024-01-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01854554

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01854554, "Glioblastoma Multiforme (GBM) Proton vs. Intensity Modulated Radiotherapy (IMRT)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01854554. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*